ABSTRACT
Objectives Currently available COVID-19 prognostic models have focused on laboratory and radiological data obtained following admission. However, these tests are not available on initial assessment or in resource-limited settings. We aim to develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of COVID-19, to identify patients at risk of critical outcomes.
Methods We used data from the SEMI-COVID-19 Registry, a nationwide multicenter cohort of consecutive patients hospitalized for COVID-19 from 132 centers in Spain. Clinical signs and symptoms, demographic variables, and medical history ascertained at hospital admission were screened using Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression to construct a predictive model. We externally validated the final model in a separate cohort of patients admitted at less-complex hospitals (< 300 beds).We undertook decision curve analysis to assess the clinical usefulness of the predictive model. The primary outcome was a composite of in-hospital death, mechanical ventilation or admission to intensive care unit.
Results There were 10,433 patients, 7,850 (primary outcome 25.1%) in the development cohort and 2,583 (primary outcome 27.0%) in the validation cohort. Variables in the final model included: age, cardiovascular disease, chronic kidney disease, dyspnea, tachypnea, confusion, systolic blood pressure, and SpO2≤93% or oxygen requirement.The C-statistic in the development cohort was 0.823 (95% CI,0.813-0.834). On external validation, the C-statistic was 0.792 (95% CI,0.772-0.812). The model showed a positive net benefit for threshold probabilities between 3% and 79%.
Conclusions Among patients presenting with COVID-19, the model based on easily-obtained clinical information had good discrimination and generalizability for identifying patients at risk of critical outcomes without the need of additional testing. The online calculator provided would facilitate triage of patients during the pandemic. This study could provide a useful tool for decision-making in health systems under pandemic pressure and resource-limited settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Authors declare that all relevant ethical guidelines have been followed, all necessary IRB and/or ethics committee approvals have been obtained, all necessary patient/participant consent has been obtained and the appropriate institutional forms archived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Objectives Currently available COVID-19 prognostic models have focused on laboratory and radiological data obtained following admission. However, these tests are not available on initial assessment or in resource-limited settings. We aim to develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of COVID-19, to identify patients at risk of critical outcomes. Methods We used data from the SEMI-COVID-19 Registry, a nationwide multicenter cohort of consecutive patients hospitalized for COVID-19 from 132 centers in Spain. Clinical signs and symptoms, demographic variables, and medical history ascertained at hospital admission were screened using Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression to construct a predictive model. We externally validated the final model in a separate cohort of patients admitted at less-complex hospitals (< 300 beds).We undertook decision curve analysis to assess the clinical usefulness of the predictive model. The primary outcome was a composite of in-hospital death, mechanical ventilation or admission to intensive care unit. Results There were 10,433 patients, 7,850 (primary outcome 25.1%) in the development cohort and 2,583 (primary outcome 27.0%) in the validation cohort. Variables in the final model included: age, cardiovascular disease, chronic kidney disease, dyspnea, tachypnea, confusion, systolic blood pressure, and SpO2≤93% or oxygen requirement.The C-statistic in the development cohort was 0.823 (95% CI,0.813-0.834). On external validation, the C-statistic was 0.792 (95% CI,0.772-0.812). The model showed a positive net benefit for threshold probabilities between 3% and 79%. Conclusions Among patients presenting with COVID-19, the model based on easily-obtained clinical information had good discrimination and generalizability for identifying patients at risk of critical outcomes without the need of additional testing. The online calculator provided would facilitate triage of patients during the pandemic. This study could provide a useful tool for decision-making in health systems under pandemic pressure and resource-limited settings.
Data Availability
The data that support the findings of this study are available on request from the SEMI-COVID-19 Registry Coordinating Center, S&H Medical Science Service and the corresponding author, [LM].
